Importer of Controlled Substances Application: S&B Pharma LLC dba Norac Pharma, 2458 [2021-00326]
Download as PDF
<![CDATA[
2458
Federal Register / Vol. 86, No. 7 / Tuesday, January 12, 2021 / Notices
Controlled substance
Drug code
Morphine ..........................................................................................................................................................................
The company plans to synthesize the
above listed control substances for
distribution to its customers. In
reference to drug codes 7360
(Marihuana) and 7370
(Tetrahydrocannabinol), the company
plans to bulk manufacture these drugs
as synthetics. No other activity for these
drug codes are authorized for this
registration.
William T. McDermott,
Assistant Administrator.
In
accordance with 21 CFR 1301.34(a), this
is notice that on August 25, 2020, S&B
Pharma LLC, dba: Norac Pharma, 405
South Motor Avenue, Azusa, California
91702, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
4-Anilino-N-phenethyl-4piperidine (ANPP).
Tapentadol ....................
[FR Doc. 2021–00356 Filed 1–11–21; 8:45 am]
Schedule
8333
II
9780
II
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–762]
Importer of Controlled Substances
Application: S&B Pharma LLC dba
Norac Pharma
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
S&B Pharma LLC, dba: Norac
Pharma has applied to be registered as
an importer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before February 11, 2021. Such
persons may also file a written request
for a hearing on the application on or
before February 11, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:09 Jan 11, 2021
Jkt 253001
The company plans to import the
listed controlled substances in bulk for
the manufacture of controlled
substances for distribution to its
customers. No other activity for these
drug codes is authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–00326 Filed 1–11–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–764]
Bulk Manufacturer of Controlled
Substances Application: Siegfried
USA, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
9300
Schedule
II
hearing on the application on or before
March 15, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
In
accordance with 21 CFR 1301.33(a), this
is notice that on December 9, 2020,
Siegfried USA, LLC, 33 Industrial Park
Road, Pennsville, New Jersey 08070–
3244, applied to be registered as an bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Gamma Hydroxybutyric
Acid.
Amphetamine ...............
Methylphenidate ...........
Amobarbital ..................
Pentobarbital ................
Secobarbital ..................
Codeine ........................
Oxycodone ...................
Hydromorphone ............
Hydrocodone ................
Methadone ....................
Methadone intermediate
Morphine .......................
Oripavine ......................
Thebaine .......................
Opium tincture ..............
Oxymorphone ...............
Tapentadol ....................
Drug
code
Schedule
2010
I
1100
1724
2125
2270
2315
9050
9143
9150
9193
9250
9254
9300
9330
9333
9630
9652
9780
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to bulk
manufacture the listed controlled
substances in bulk for sale to its
customers. No other activities for these
drug codes are authorized for this
registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–00354 Filed 1–11–21; 8:45 am]
BILLING CODE P
Siegfried USA, LLC has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 15, 2021. Such persons
may also file a written request for a
SUMMARY:
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–760]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturer of Marihuana: Natural
Fulfillment LLC
Drug Enforcement
Administration, Justice.
AGENCY:
E:\FR\FM\12JAN1.SGM
12JAN1
]]>Agencies
[Federal Register Volume 86, Number 7 (Tuesday, January 12, 2021)]
[Notices]
[Page 2458]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00326]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-762]
Importer of Controlled Substances Application: S&B Pharma LLC dba
Norac Pharma
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: S&B Pharma LLC, dba: Norac Pharma has applied to be registered
as an importer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before February 11,
2021. Such persons may also file a written request for a hearing on the
application on or before February 11, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on August 25, 2020, S&B Pharma LLC, dba: Norac Pharma,
405 South Motor Avenue, Azusa, California 91702, applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
4-Anilino-N-phenethyl-4-piperidine 8333 II
(ANPP).
Tapentadol............................. 9780 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances in
bulk for the manufacture of controlled substances for distribution to
its customers. No other activity for these drug codes is authorized for
this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-00326 Filed 1-11-21; 8:45 am]
BILLING CODE P
